Primatene Mist No Longer On the Shelves – The only over-the-counter asthma inhaler is no longer available as of Jan 1st, as part of the phase-out of epinephrine inhalers containing chlorofluorocarbons (CFCs).
Civitas Therapeutics Announced Positive Results from clinical study of CVT-301, an inhaled L-Dopa formulation for Parkinson’s disease.
FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza’s ADASUVE(TM) for treatment of agitation in patients with schizophrenia or bipolar mania.
Budesonide / Formoterol pMDI Inhaler Reduces COPD Exacerbations
